• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢疾病和阿尔茨海默病中的内体溶酶体功能障碍。

Endosomal-lysosomal dysfunction in metabolic diseases and Alzheimer's disease.

机构信息

Biotechnology Research and Training Center, University of North Carolina-Pembroke, Pembroke, NC, United States.

Department of Biology and Marine Biology, University of North Carolina-Wilmington, Wilmington, NC, United States.

出版信息

Int Rev Neurobiol. 2020;154:303-324. doi: 10.1016/bs.irn.2020.02.012. Epub 2020 Jul 10.

DOI:10.1016/bs.irn.2020.02.012
PMID:32739009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8428780/
Abstract

The endosomal-lysosomal pathways and related autophagic processes are responsible for proteostasis, involving complexes between lysosomes and autophagosomes. Lysosomes are a key component of homeostasis, involved in cell signaling, metabolism, and quality control, and they experience functional compromise in metabolic diseases, aging, and neurodegenerative diseases. Many genetic mutations and risk factor genes associated with proteinopathies, as well as with metabolic diseases like diabetes, negatively influence endocytic trafficking and autophagic clearance. In contrast, health-improving exercise induces autophagy-lysosomal degradation, perhaps promoting efficient digestion of injured organelles so that undamaged organelles ensure cellular healthiness. Reductions in lysosomal hydrolases are implicated in Alzheimer's, Parkinson's, and lysosomal storage diseases, as well as obesity-related pathology, and members of the cathepsin enzyme family are involved in clearing both Aβ42 and α-synuclein. Upregulation of cathepsin hydrolases improves synaptic and memory functions in models of dementia and in exercising humans, thus identifying lysosomal-related systems as vital for healthy cognitive aging.

摘要

内体溶酶体途径和相关的自噬过程负责蛋白质稳态,涉及溶酶体和自噬体之间的复合物。溶酶体是体内平衡的关键组成部分,参与细胞信号转导、代谢和质量控制,并且在代谢疾病、衰老和神经退行性疾病中经历功能障碍。许多与蛋白病以及糖尿病等代谢疾病相关的遗传突变和风险因素基因,会对内吞作用和自噬清除产生负面影响。相反,有益健康的运动诱导自噬溶酶体降解,可能促进受损细胞器的有效消化,从而使未受损的细胞器确保细胞健康。溶酶体水解酶的减少与阿尔茨海默病、帕金森病和溶酶体贮积病以及与肥胖相关的病理学有关,组织蛋白酶酶家族的成员参与清除 Aβ42 和 α-突触核蛋白。组织蛋白酶水解酶的上调改善了痴呆症模型和运动人群中的突触和记忆功能,从而确定了与溶酶体相关的系统对健康认知衰老至关重要。

相似文献

1
Endosomal-lysosomal dysfunction in metabolic diseases and Alzheimer's disease.代谢疾病和阿尔茨海默病中的内体溶酶体功能障碍。
Int Rev Neurobiol. 2020;154:303-324. doi: 10.1016/bs.irn.2020.02.012. Epub 2020 Jul 10.
2
The Role of Lysosomes in a Broad Disease-Modifying Approach Evaluated across Transgenic Mouse Models of Alzheimer's Disease and Parkinson's Disease and Models of Mild Cognitive Impairment.溶酶体在广泛的疾病修饰方法中的作用,在阿尔茨海默病和帕金森病的转基因小鼠模型以及轻度认知障碍模型中进行了评估。
Int J Mol Sci. 2019 Sep 9;20(18):4432. doi: 10.3390/ijms20184432.
3
The aging lysosome: An essential catalyst for late-onset neurodegenerative diseases.衰老的溶酶体:晚期神经退行性疾病的必要催化剂。
Biochim Biophys Acta Proteins Proteom. 2020 Sep;1868(9):140443. doi: 10.1016/j.bbapap.2020.140443. Epub 2020 May 13.
4
Endo-lysosomal and autophagic dysfunction: a driving factor in Alzheimer's disease?内溶酶体与自噬功能障碍:阿尔茨海默病的驱动因素?
J Neurochem. 2017 Mar;140(5):703-717. doi: 10.1111/jnc.13935. Epub 2017 Jan 23.
5
Neurodegenerative lysosomal disorders: a continuum from development to late age.神经退行性溶酶体疾病:从发育到老年的连续过程。
Autophagy. 2008 Jul;4(5):590-9. doi: 10.4161/auto.6259. Epub 2008 May 12.
6
Loss of Cathepsin B and L Leads to Lysosomal Dysfunction, NPC-Like Cholesterol Sequestration and Accumulation of the Key Alzheimer's Proteins.组织蛋白酶B和L的缺失导致溶酶体功能障碍、NPC样胆固醇隔离以及关键阿尔茨海默病蛋白的积累。
PLoS One. 2016 Nov 30;11(11):e0167428. doi: 10.1371/journal.pone.0167428. eCollection 2016.
7
The secret life of degradative lysosomes in axons: delivery from the soma, enzymatic activity, and local autophagic clearance.轴突中降解性溶酶体的秘密生活:从胞体的输送、酶活性和局部自噬清除。
Autophagy. 2020 Jan;16(1):167-168. doi: 10.1080/15548627.2019.1669869. Epub 2019 Sep 23.
8
Potential compensatory responses through autophagic/lysosomal pathways in neurodegenerative diseases.神经退行性疾病中通过自噬/溶酶体途径的潜在代偿反应。
Autophagy. 2006 Jul-Sep;2(3):234-7. doi: 10.4161/auto.2729. Epub 2006 Jul 22.
9
Endosomal-lysosomal dysfunctions in Alzheimer's disease: Pathogenesis and therapeutic interventions.阿尔茨海默病中的内体溶酶体功能障碍:发病机制和治疗干预。
Metab Brain Dis. 2021 Aug;36(6):1087-1100. doi: 10.1007/s11011-021-00737-0. Epub 2021 Apr 21.
10
Cross-regulation of defective endolysosome trafficking and enhanced autophagy through TFEB in UNC13D deficiency.UNC13D 缺陷通过 TFEB 导致内溶酶体运输缺陷和自噬增强的交叉调控。
Autophagy. 2019 Oct;15(10):1738-1756. doi: 10.1080/15548627.2019.1596475. Epub 2019 Apr 5.

引用本文的文献

1
Nanotechnology for Neurodegenerative Diseases: Recent Progress in Brain-Targeted Delivery, Stimuli-Responsive Platforms, and Organelle-Specific Therapeutics.用于神经退行性疾病的纳米技术:脑靶向递送、刺激响应平台和细胞器特异性治疗的最新进展
Int J Nanomedicine. 2025 Sep 9;20:11015-11044. doi: 10.2147/IJN.S549893. eCollection 2025.
2
Critical Review on Molecular Mechanisms for Genistein's Beneficial Effects on Health Through Oxidative Stress Reduction.关于染料木黄酮通过减轻氧化应激对健康产生有益影响的分子机制的批判性综述
Antioxidants (Basel). 2025 Jul 24;14(8):904. doi: 10.3390/antiox14080904.
3
Loss of lysosomal acid lipase contributes to Alzheimer's disease pathology and cognitive decline.溶酶体酸性脂肪酶的缺失会导致阿尔茨海默病的病理变化和认知能力下降。
Alzheimers Dement. 2025 Jul;21(7):e70486. doi: 10.1002/alz.70486.
4
Exercise orchestrates systemic metabolic and neuroimmune homeostasis via the brain-muscle-liver axis to slow down aging and neurodegeneration: a narrative review.运动通过脑-肌肉-肝脏轴协调全身代谢和神经免疫稳态,以减缓衰老和神经退行性变:一项叙述性综述。
Eur J Med Res. 2025 Jun 12;30(1):475. doi: 10.1186/s40001-025-02751-9.
5
Lysosomes' fallback strategies: more than just survival or death.溶酶体的备用策略:不止是生存或死亡。
Front Cell Dev Biol. 2025 Mar 11;13:1559504. doi: 10.3389/fcell.2025.1559504. eCollection 2025.
6
Excessive Alcohol Use as a Risk Factor for Alzheimer's Disease: Epidemiological and Preclinical Evidence.过度饮酒作为阿尔茨海默病的一个风险因素:流行病学和临床前证据。
Adv Exp Med Biol. 2025;1473:211-242. doi: 10.1007/978-3-031-81908-7_10.
7
A kaleidoscopic view of extracellular vesicles in lysosomal storage disorders.溶酶体贮积症中细胞外囊泡的千变万化景象。
Extracell Vesicles Circ Nucl Acids. 2022 Dec 30;3(4):393-421. doi: 10.20517/evcna.2022.41. eCollection 2022.
8
Broadening Horizons: Exploring the Cathepsin Family as Therapeutic Targets for Alzheimer's Disease.拓展视野:探索组织蛋白酶家族作为阿尔茨海默病的治疗靶点
Aging Dis. 2024 Jul 27. doi: 10.14336/AD.2024.0456.
9
Mechanisms of autophagy-lysosome dysfunction in neurodegenerative diseases.神经退行性疾病中自噬-溶酶体功能障碍的机制。
Nat Rev Mol Cell Biol. 2024 Nov;25(11):926-946. doi: 10.1038/s41580-024-00757-5. Epub 2024 Aug 6.
10
Loss of neuronal lysosomal acid lipase drives amyloid pathology in Alzheimer's disease.神经元溶酶体酸性脂肪酶的缺失导致阿尔茨海默病中的淀粉样蛋白病变。
bioRxiv. 2024 Jun 10:2024.06.09.596693. doi: 10.1101/2024.06.09.596693.

本文引用的文献

1
Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations: A Nonrandomized, Noncontrolled Trial.氨溴索治疗伴有和不伴有葡萄糖脑苷脂酶基因突变的帕金森病患者:一项非随机、非对照试验。
JAMA Neurol. 2020 Apr 1;77(4):427-434. doi: 10.1001/jamaneurol.2019.4611.
2
Active lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degeneration.积极的生活方式可改善常染色体显性额颞叶变性的临床结局。
Alzheimers Dement. 2020 Jan;16(1):91-105. doi: 10.1002/alz.12001.
3
Promoting tau secretion and propagation by hyperactive p300/CBP via autophagy-lysosomal pathway in tauopathy.通过自噬溶酶体途径过度活跃的 p300/CBP 促进 tau 分泌和传播在 tau 病中。
Mol Neurodegener. 2020 Jan 6;15(1):2. doi: 10.1186/s13024-019-0354-0.
4
The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunction.α-突触核蛋白聚集与自噬溶酶体功能障碍之间的恶性循环。
Mov Disord. 2020 Jan;35(1):34-44. doi: 10.1002/mds.27895. Epub 2019 Nov 15.
5
Cellular quality control by the ubiquitin-proteasome system and autophagy.细胞的泛素-蛋白酶体系统和自噬的质量控制。
Science. 2019 Nov 15;366(6467):818-822. doi: 10.1126/science.aax3769. Epub 2019 Nov 14.
6
Nutrient regulation of mTORC1 at a glance.mTORC1 的营养素调控一览
J Cell Sci. 2019 Nov 13;132(21):jcs222570. doi: 10.1242/jcs.222570.
7
Lysosomal Dysfunction at the Centre of Parkinson's Disease and Frontotemporal Dementia/Amyotrophic Lateral Sclerosis.溶酶体功能障碍与帕金森病、额颞叶痴呆/肌萎缩性侧索硬化症的中心地位。
Trends Neurosci. 2019 Dec;42(12):899-912. doi: 10.1016/j.tins.2019.10.002. Epub 2019 Nov 5.
8
Individualized clinical management of patients at risk for Alzheimer's dementia.对有阿尔茨海默病风险的患者进行个体化临床管理。
Alzheimers Dement. 2019 Dec;15(12):1588-1602. doi: 10.1016/j.jalz.2019.08.198. Epub 2019 Oct 31.
9
Allele-selective lowering of mutant HTT protein by HTT-LC3 linker compounds.通过 HTT-LC3 连接化合物降低突变 HTT 蛋白的等位基因选择性。
Nature. 2019 Nov;575(7781):203-209. doi: 10.1038/s41586-019-1722-1. Epub 2019 Oct 30.
10
ApoE4 Alters ABCA1 Membrane Trafficking in Astrocytes.载脂蛋白 E4 改变星形胶质细胞中的 ABCA1 膜运输。
J Neurosci. 2019 Nov 27;39(48):9611-9622. doi: 10.1523/JNEUROSCI.1400-19.2019. Epub 2019 Oct 22.